The prevalence and pattern of pharmaceutical and excipient exposure in a neonatal unit in Slovenia
Open Access
- 11 November 2014
- journal article
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 28 (17) , 2053-2061
Abstract
Because of the restraints on conducting studies on pharmaceutical use in sick newborns, many drugs are used off-label in this population. Moreover, industrially manufactured pharmaceuticals may contain different excipients, which may be either untested or not licensed for use in neonates. The aim of our study was to determine the prevalence and pattern of pharmaceutical and excipient exposure in newborns hospitalized at the Department of Neonatology, Ljubljana, Slovenia. A longitudinal prospective cross-sectional study was performed during a one-month period and included all hospitalized neonates. Route of administration, site of action, type of manufacture, licensing status, type and concentrations of excipients for all pharmaceuticals given to the neonates were determined. Twenty seven different pharmaceutical preparations were prescribed to a total of 48 hospitalized newborns. In most cases, newborns were prescribed various pharmaceuticals that were not approved for use in this population. Newborns were exposed to 60 different excipients in industrially manufactured pharmaceutical preparations. More than half of the received pharmaceuticals contained potentially harmful and harmful excipients. Two-thirds of pharmaceutical preparations for neonates were used off-label. Newborns receive more auxiliary substances, which may be unsuitable for this age group and may even be toxic to them, via industrially manufactured pharmaceuticals.Keywords
This publication has 15 references indexed in Scilit:
- Risk assessment of neonatal excipient exposure: Lessons from food safety and other areasAdvanced Drug Delivery Reviews, 2014
- Hospitalised neonates in Estonia commonly receive potentially harmful excipientsBMC Pediatrics, 2012
- Pharmacological research in neonatologyThe Journal of Maternal-Fetal & Neonatal Medicine, 2011
- Off-label drugs prescription in neonatology: a physician’s duty or a medical hazardous attitude?The Journal of Maternal-Fetal & Neonatal Medicine, 2011
- Paediatric pharmacology: Remember the excipientsPharmacological Research, 2011
- Drug policy in EuropeEarly Human Development, 2011
- Unlicensed and off‐label drug use in a neonatal unit in FranceActa Paediatrica, 2010
- Unlicensed and off-label use of medicines at a neonatology clinic in ItalyPharmacy World & Science, 2007
- Unlicensed and off-label drug use in a paediatric ward of a general hospital in the NetherlandsEuropean Journal of Clinical Pharmacology, 2002
- “Inactive” Ingredients in Pharmaceutical Products: Update (Subject Review)Pediatrics, 1997